Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

First DNA test for canine glaucoma launches at AHT
Gavin Robertson with petit basset griffon vendeen
Gavin Robertson is chairman of the Basset Griffon Vandeen Club and owner of best in show 2013 winner Jilly.

Researchers identify mutation causing a type of primary glaucoma

A new DNA test for canine glaucoma has been developed at the Animal Health Trust (AHT), after researchers were able to identify the mutation behind primary open angle glaucoma (POAG) in petit basset griffon vendéens.

Glaucoma causes pain and blindness due to reduced drainage from the eye, which results in a build-up of pressure.

Primary glaucoma is an inherited condition divided into two forms - open angle and closed angle glaucoma. For closed angle glaucoma, a screening technique called gonioscopy is available to identify at-risk dogs.

The test for POAG has been developed at the AHT's Kennel Club Genetics Centre, following several years of research using DNA samples provided by owners and breeders.

Currently, the petit basset griffon vendéen is the only UK breed that is certified under the BVA/KC/ISDS Eye Scheme for POAG.

Dr Cathryn Mellersh, head of the genetics centre at AHT, said: "As there is no clinical test available to screen these dogs for POAG prior to the onset of the disease, it has been challenging for breeders to control.

"Now, any petit basset griffon vendéen can have the non-invasive DNA test, collected via a simple cheek swab, giving the owner peace of mind about both the dog’s eye health and if it is a carrier of the genetic mutation.

"Hopefully, with responsible DNA testing and breeding, we will be able to eradicate this painful and blinding condition from the petit basset griffon vendéen population."

Going forward, the centre plans to explore the genetics behind closed angle glaucoma in dogs, which affects a larger number of breeds.

The new test has been welcomed by Gavin Robertson, who is chairman of the Basset Griffon Vandeen (BGV) Club and the owner of the 2013 Crufts best in show winner, a petit basset griffon vendéen called Jilly.

"Through years of hard work, hundreds of eye tests and the submission of DNA the BGV Club are absolutely delighted that Dr Cathryn Mellersh and her team at the Animal Health Trust have identified and carried out validation experiments on the DNA responsible for POAG in the petit basset griffon vendéen," he commented.

The test will be available from the AHT DNA testing service from March 5, 2015 at a full cost of £48. A limited number of £6 off discount vouchers will be available from the AHT's stand at Crufts (stand 3-55).

Image © OnEdition, The Kennel Club

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.